Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 5 subfamily A member 2 (OR5A2) is a member of the olfactory receptor gene family, which constitutes the largest group of G protein-coupled receptors (GPCRs) in the human genome[2][3]. OR5A2 is principally expressed in the olfactory epithelium of the nose, where it recognizes specific odorant molecules and initiates neuronal signaling pathways, ultimately leading to the perception of smell[2][3][4][5]. The protein characteristically spans the cell membrane seven times, sharing this 7-transmembrane domain structure with many neurotransmitter and hormone receptors[2][4][5]. Although OR5A2 is a typical olfactory GPCR—with a canonical role in olfaction—olfactory receptors as a class have been implicated in additional physiological roles outside the olfactory system, but there is no direct evidence of such roles for OR5A2[3]. There are currently no approved drugs or direct therapeutic interventions targeting this receptor[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 5 subfamily A member 2 (OR5A2).